OBJECTIVE: To evaluate the synthesis of major cytokines characteristic of Th1/Th2/Th17 immune responses in children with congenital cleft lip and palate in acute CAPeumonia.

MATERIAL AND METHODS: The present study included 46 children with an established diagnosis of community acquired pneumonia (22 children with CCLP and 24 children without CCLP formed the comparison group) and 20 practically healthy children formed the control group. The concentration of interleukins and interferon-γ in the blood serum was determined by the method of solid-phase enzyme-linked immunosorbent assay (ELISA) using the test systems of Vector-Best JSC (Novosibirsk, Russia).

RESULTS: It was found that in groups of children with CAP, both with congenital cleft lip and without congenital pathology, there was a significant increase in the content of IL-17A, IL-4 in the peripheral blood and a deficiency of IFN-γ in young children, which indicates an imbalance in the immune response that can affect the course and severity of the infection.

Early childhood, cleft lip and palate, pneumonia

Eyni, Y., et al., Risk of CAPeumonia among children with cleft palate before and after palatoplasty: a population-based study. Eur J Pediatr, 2024. 184(1): p. 56.

Gritsinskaya VL, Novikova VP. Frequently ill children: a new look at an old problem. Medical Council. 2024;(19):224-229.

Musakhodjaeva D.A., Inoyatov A.Sh., Sharopov S.G. Analysis of modern views on risk factors for the development of congenital malformations of the maxillofacial region. New day in medicine, (Tashkent) 2019.51-54.

Karimjonov IA, Madraximov PM Characteristics of immunological disorders in acute CAPeumonia and frequently sick children. // Re-health journal-2021/-1(9):126-129.

Musakhodzhaeva D.A., Inoyatov A.Sh., Sharopov S.G. Cytokine profile in children with congenital cleft lip and palate Eurasian Union of Scientists, 2019. Art. 50-54.

Nesterova IV, Kovaleva SV, Chudilova GA, Malinovskaya VV Interferon and immunotherapy in the rehabilitation of immunocompromised children with recurrent respiratory infections. In: Immunoterapiya v paktike ENT-vracha i terapevta. AS Simbirsev, GV Lavrenova (eds.). Sankt-Peterburg: Dialog. 2018: 167-89.

Cătană CS, Neagoe IB, Cozma V, Magdaş C, Tăbăran F, Dumitraşcu DL. Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease. World J Gastroenterol. 2018; 21:5823 - 5830.

Mandy J McGeachy , Daniel J Cua , Sarah L Gaffen . “The IL-17 Family of Cytokines in Health and Disease” I mmunity 2019 Apr 16;50(4):892-906.

Burke JD, Young HA. IFN- γ: a cytokine at the right time, is in the right place. Semin Immunol. 2019; 43:1 - 8.

SC Wilson, NA Caveney, M Yen, C Pollmann, X Xiang. Organizing structural principles of the IL-17 ligand–receptor axis. Nature 2022 :556 -567.